Agilent Technologies Inc
A
$146.36 2.09%
Exchange: NYSE | Sector: Healthcare | Industry: Medical Diagnostics Research
Q2 2025
Published: Jun 2, 2025

Earnings Highlights

  • Revenue of $1.67B up 6% year-over-year
  • EPS of $0.75 decreased by 28.6% from previous year
  • Gross margin of 53.5%
  • Net income of 215.00M
  • ""No matter where I travel in the world, our customers consistently say the same thing. The Agilent team is second to none and for that reason, they want to increase their partnership and collaboration with us even more" - Padraig McDonnell" - Padraig McDonnell

Agilent Technologies Inc (A) Q2 2025 Financial Results: Resilient Growth Amidst Challenges

Executive Summary

Agilent Technologies Inc reported a solid second quarter for fiscal 2025, showcasing a revenue increase of 6% year-over-year to $1.67 billion, driven by growth in all business segments and geographies. The effective management of tariff costs and strong demand in key markets such as Diagnostics and Clinical as well as the Agilent CrossLab Group fueled this performance. The company also delivered earnings per share (EPS) of $1.31, representing a 7% increase from the prior year, marking four consecutive quarters of accelerating growth. Management emphasized their commitment to long-term strategies, including their three-year Ignite transformation program aimed at enhancing operational efficiency and profitability.

Key Performance Indicators

Revenue

1.67B
QoQ: -0.77% | YoY:6.04%

Gross Profit

893.00M
53.54% margin
QoQ: -0.89% | YoY:4.32%

Operating Income

300.00M
QoQ: -20.21% | YoY:-17.36%

Net Income

215.00M
QoQ: -32.39% | YoY:-30.19%

EPS

0.75
QoQ: -33.04% | YoY:-28.57%

Revenue Trend

Margin Analysis

Key Insights

  • **Revenue**: $1.67 billion, a YoY increase of 6.04%
  • **Operating Income**: $300 million, reflecting an operating margin of 25.1%
  • **Net Income**: $215 million, translating to a net income margin of approximately 12.9%
  • **EPS**: $1.31, up 7% YoY.
  • **YoY core revenue growth**: 5.3%, adjusted for currency impacts.

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 1,668.00 0.75 +6.0% View
Q1 2025 1,681.00 1.11 +1.4% View
Q4 2024 1,701.00 1.21 +0.8% View
Q3 2024 1,578.00 0.97 -5.6% View
Q2 2024 1,573.00 1.05 -8.4% View